Tyrosine kinase inhibitors in non-small cell lung and pancreatic cancer: the emerging role of erlotinib. [electronic resource]
Producer: 20071121Description: S137-49 p. digitalISSN:- 1107-0625
- Animals
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Agents -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Deoxycytidine -- analogs & derivatives
- Drug Resistance, Neoplasm
- Erlotinib Hydrochloride
- Gene Expression Regulation, Enzymologic
- Gene Expression Regulation, Neoplastic
- Genetic Testing
- Humans
- Lung Neoplasms -- drug therapy
- Mutation
- Pancreatic Neoplasms -- drug therapy
- Patient Selection
- Protein Kinase Inhibitors -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Quinazolines -- pharmacology
- Receptor, ErbB-2 -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.